SCHEMBL8416539

SCHEMBL8416539

Cc1nc(Cl)c(Cl)n1CCCCN1CCN(c2ccccc2F)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.55
DRD2 P14416 4/20 0.55
HRH1 P35367 1/20 0.55
ADRA1A P35348 2/20 0.50
DRD3 P35462 2/20 0.50
SIGMAR1 Q99720 1/20 0.50
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
CACNA1G O43497 2/20 0.47
HTR2C P28335 4/20 0.47
SLC6A4 P31645 4/20 0.47
PTGS2 P35354 1/20 0.47
HTR1A P08908 1/20 0.47
HTR7 P34969 1/20 0.47
HTR6 P50406 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
GRM2 Q14416 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416472 0.89 KDM4E (0.61) HTR2ADRD2ADRA1ADRD3KDM4E
SCHEMBL8416503 0.84 HTR1A (0.61) HTR2ADRD2HRH1DRD3SIGMAR1
SCHEMBL8416445 0.84 HTR1A (0.53) HTR2ADRD2ADRA1ADRD3KDM4E
SCHEMBL8416455 0.84 HTR1A (0.62) HTR2ADRD2ADRA1ADRD3SLC6A4
SCHEMBL8418004 0.79 HTR1A (0.48) HTR2ADRD2DRD3HTR1AHTR7
SCHEMBL7474002 0.79 SIGMAR1 (0.53) DRD2SIGMAR1KDM4EHTR1A
SCHEMBL8417661 0.76 HTR2A (0.58) HTR2ADRD2HTR1AHTR7HTR6
SCHEMBL8416352 0.76 SIGMAR1 (0.57) DRD2ADRA1ADRD3SIGMAR1HTR1A
SCHEMBL8418003 0.75 HSD17B10 (0.56) HTR2ADRD2ADRA1ADRD3HTR1A
SCHEMBL946834 0.75 SIGMAR1 (0.59) HTR2ADRD2HRH1ADRA1ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0655248-B1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion ESTEVE LABOR DR (ES) 1999-09-15 EP claimed
US-5532234-A Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion LABORATORIES DEL DR. ESTEVE, S.A. (ES) 1996-07-02 US claimed
EP-0655248-A1 Use of 1-4-4-aryl(or heteroaryl)-1-piperazinylbutyl-1H-azole derivatives for the preparation of medicaments for the treatment of disorders of gastric secretion LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1995-05-31 EP claimed
EP-0808166-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-11-26 EP disclosed
WO-1997021439-A1 MEDICAMENT INTENDED TO THE TREATMENT OF OBSESSIVE COMPULSIVE TROUBLES, SLEEP APNOEA, SEXUAL DYSFUNCTIONS, EMESA AND TRANSPORT SICKNESS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1997-06-19 WO disclosed